Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of effects of pitavastatin and atorvastatin on glucose metabolism in type 2 diabetic patients with hypercholesterolemia
Tomoya Mita, Shiho Nakayama, Hiroko Abe, et al.
Journal of Diabetes Investigation (2013) Vol. 4, Iss. 3, pp. 297-303
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor
Alexander Tenenbaum, Robert Klempfner, Enrique Z. Fisman
Cardiovascular Diabetology (2014) Vol. 13, Iss. 1
Open Access | Times Cited: 154
Risk of diabetes in patients treated with HMG-CoA reductase inhibitors
Yongin Cho, Eun-Yeong Choe, Yong‐ho Lee, et al.
Metabolism (2014) Vol. 64, Iss. 4, pp. 482-488
Closed Access | Times Cited: 67
Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin
Lorenzo Arnaboldi, Alberto Corsini
Atherosclerosis Supplements (2015) Vol. 16, pp. 1-27
Closed Access | Times Cited: 48
Outcome of pitavastatin versus atorvastatin therapy in patients with hypercholesterolemia at high risk for atherosclerotic cardiovascular disease
Masao Moroi, Daiji Nagayama, Fumihiko Hara, et al.
International Journal of Cardiology (2020) Vol. 305, pp. 139-146
Open Access | Times Cited: 29
Pathogenesis and Management of the Diabetogenic Effect of Statins: a Role for Adiponectin and Coenzyme Q10?
Dick C. Chan, Jing Pang, Gerald F. Watts
Current Atherosclerosis Reports (2014) Vol. 17, Iss. 1
Closed Access | Times Cited: 34
The good and bad effects of statins on insulin sensitivity and secretion
Giovanna Muscogiuri, Gerardo Sarno, Amalia Gastaldelli, et al.
Endocrine Research (2014) Vol. 39, Iss. 4, pp. 137-143
Closed Access | Times Cited: 31
Statins and risk for new-onset diabetes mellitus
Dukyong Yoon, Seung Soo Sheen, Sukhyang Lee, et al.
Medicine (2016) Vol. 95, Iss. 46, pp. e5429-e5429
Open Access | Times Cited: 31
Statin Intolerance Clinical Guide 2018
Kouji Kajinami, Kazuhisa Tsukamoto, Shinji Koba, et al.
Journal of Atherosclerosis and Thrombosis (2019) Vol. 27, Iss. 4, pp. 375-396
Open Access | Times Cited: 27
Is statin‐induced diabetes clinically relevant? A comprehensive review of the literature
David S.H. Bell, James J. DiNicolantonio, James H. O’Keefe
Diabetes Obesity and Metabolism (2013) Vol. 16, Iss. 8, pp. 689-694
Closed Access | Times Cited: 29
New-Onset Diabetes and Statins: Throw the Bath Water Out, But, Please, Keep the Baby!
Niki Katsiki, Manfredi Rizzo, Dimitri P. Mikhailidis, et al.
Metabolism (2014) Vol. 64, Iss. 4, pp. 471-475
Closed Access | Times Cited: 27
Pitavastatin improves glycated hemoglobin in patients with poorly controlled type 2 diabetes
Chung‐Huei Huang, Yu‐Yao Huang, Brend Ray‐Sea Hsu
Journal of Diabetes Investigation (2016) Vol. 7, Iss. 5, pp. 769-776
Open Access | Times Cited: 25
Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor
Alexander Tenenbaum, Robert Klempfner, Enrique Z. Fisman
Cardiovascular Diabetology (2014) Vol. 13, Iss. 1, pp. 159-159
Open Access | Times Cited: 23
Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trial
Mabel Toribio, Kathleen V. Fitch, Lauren Stone, et al.
EBioMedicine (2018) Vol. 35, pp. 58-66
Open Access | Times Cited: 20
CAVI-Lowering Effect of Pitavastatin May Be Involved in the Prevention of Cardiovascular Disease: Subgroup Analysis of the TOHO-LIP
Atsuhito Saiki, Yasuhiro Watanabe, Takashi Yamaguchi, et al.
Journal of Atherosclerosis and Thrombosis (2020) Vol. 28, Iss. 10, pp. 1083-1094
Open Access | Times Cited: 17
Clinical Benefits of Pitavastatin: Focus On Patients With Diabetes Or at Risk of Developing Diabetes
Vivencio Barrios, Carlos Escobar
Future Cardiology (2016) Vol. 12, Iss. 4, pp. 449-466
Closed Access | Times Cited: 14
Pitavastatin and carbohydrate metabolism: what is the evidence?
Theodosios D. Filippatos, Moses Elisaf
Expert Review of Clinical Pharmacology (2016) Vol. 9, Iss. 7, pp. 955-960
Closed Access | Times Cited: 12
Real-World Analyses of the Safety Outcome among a General Population Treated with Statins: An Asian Population-Based Study
Jia‐Ling Lin, Po-Sheng Chen, Hui‐Wen Lin, et al.
Journal of Atherosclerosis and Thrombosis (2021) Vol. 29, Iss. 8, pp. 1213-1225
Open Access | Times Cited: 11
A Systematic Review of Randomized Clinical Trials on the Efficacy and Safety of Pitavastatin
Asim Ahmed Elnour, Adel Sadeq, Farah Hamad Farah, et al.
Current Reviews in Clinical and Experimental Pharmacology (2022) Vol. 18, Iss. 2, pp. 120-147
Closed Access | Times Cited: 7
Safety and Efficacy of Pitavastatin in Patients With Impaired Fasting Glucose and Hyperlipidemia: A Randomized, Open-labeled, Multicentered, Phase IV Study
Hae‐Young Lee, Ki‐Hoon Han, Woo‐Baek Chung, et al.
Clinical Therapeutics (2020) Vol. 42, Iss. 10, pp. 2036-2048
Closed Access | Times Cited: 10
Risk and Benefits of Statins in Glucose Control Management of Type II Diabetes
Angela Felicia Sunjaya, Samuel Halim, Frans Ferdinal, et al.
International Journal of Angiology (2016) Vol. 27, Iss. 03, pp. 121-131
Open Access | Times Cited: 9
Prediction of the Presence of Insulin Resistance using General Health Checkup Data in Japanese Employees with Metabolic Risk Factors
Mitsuyoshi Takahara, Naoto Katakami, Hideaki Kaneto, et al.
Journal of Atherosclerosis and Thrombosis (2013), pp. 38-48
Open Access | Times Cited: 9
Efficacy and safety of pitavastatins in patients with acute myocardial infarction: Livalo in Acute Myocardial Infarction Study (LAMIS) II
Young Joon Hong, Myung Ho Jeong, Jang Ho Bae, et al.
The Korean Journal of Internal Medicine (2017) Vol. 32, Iss. 4, pp. 656-667
Open Access | Times Cited: 9
Long-term Effects of high-doSe pitavaStatin on Diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM): study protocol for a randomized controlled trial
Jun‐Bean Park, Ji-Hyun Jung, Yeonyee E. Yoon, et al.
Trials (2017) Vol. 18, Iss. 1
Open Access | Times Cited: 9
RSSDI consensus recommendations for dyslipidemia management in diabetes mellitus
Banshi Saboo, Sanjay Agarwal, Brij Makkar, et al.
International Journal of Diabetes in Developing Countries (2022) Vol. 42, Iss. 1, pp. 3-28
Closed Access | Times Cited: 5
New Aspects of Cellular Cholesterol Regulation on Blood Glucose Control—Review and Perspective on the Impact of Statin Medications on Metabolic Health
Brian A. Grice, Jeffrey S. Elmendorf
US Endocrinology (2017) Vol. 13, Iss. 02, pp. 63-63
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top